Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada
- PMID: 21802914
- DOI: 10.1016/j.clon.2011.07.005
Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada
Abstract
Aims: Evidence suggests that pre- and/or postoperative treatment benefits patients with stage II/III rectal cancer. This study aimed to quantify treatment patterns and adherence to treatment guidelines, and to identify barriers to having a consultation with an oncologist and barriers to receiving treatment in stage II/III rectal cancer, in a publicly funded medical care system.
Materials and methods: Patients with surgically treated stage II/III rectal adenocarcinoma, diagnosed from 2002 to 2005 in Alberta, a Canadian province with a population of 3 million, were included. Demographic and treatment information from the Alberta Cancer Registry were linked to data from electronic medical records, hospital discharge data and the 2001 Canadian Census. The study outcomes were 'not having an oncologist consultation' and 'not receiving guideline-based treatment'. The relative risks of the two outcomes in association with patient characteristics were estimated using multivariable log-binomial regression.
Results: Of a total of 910 surgically treated stage II/III rectal adenocarcinoma patients, 748 (82%) had a consultation with an oncologist and 414 (45.5%) received treatment. Pre-/post-surgical treatment modalities and timing varied; 96 (10.5%) received neoadjuvant treatment only, 389 (42.7%) received adjuvant treatment only, 119 (13.1%) received both, and 306 (33.6%) had surgery alone. Factors related to not having a consultation with an oncologist included older age, co-morbidities, cancer stage II and region of residence. Older age was the most significantly associated factor with not receiving treatment (relative risk=2.23; 95% confidence interval: 1.89, 2.64).
Conclusions: Disparities exist in the receipt of treatment in stage II/III rectal cancer. Factors such as age, region of residence and stage should not be barriers to consulting an oncologist to discuss or receive treatment. The reasons for these disparities need to be identified and addressed.
Copyright © 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.Clin Colorectal Cancer. 2009 Jul;8(3):141-5. doi: 10.3816/CCC.2009.n.023. Clin Colorectal Cancer. 2009. PMID: 19632928
-
Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline-recommended treatment.Cancer. 2010 Oct 15;116(20):4849-56. doi: 10.1002/cncr.25250. Cancer. 2010. PMID: 20578180
-
Referral rate to oncologists and its variation by hospital for colorectal cancer patients.Ann Surg Oncol. 2012 Mar;19(3):714-21. doi: 10.1245/s10434-011-2063-y. Epub 2011 Sep 16. Ann Surg Oncol. 2012. PMID: 21922337
-
[Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].Orv Hetil. 2006 Oct 22;147(42):2011-20. Orv Hetil. 2006. PMID: 17165600 Review. Hungarian.
-
Adjuvant therapy in colorectal cancer.Trop Gastroenterol. 1997 Oct-Dec;18(4):139-44. Trop Gastroenterol. 1997. PMID: 9612092 Review.
Cited by
-
Integrated care pathway for rectal cancer treatment: cross-sectional post-implementation study using a logic model framework.Sao Paulo Med J. 2019 Sep-Oct;137(5):438-445. doi: 10.1590/1516-3180.2018.0364160919. Sao Paulo Med J. 2019. PMID: 31939569 Free PMC article.
-
Characteristics affecting survival after locally advanced colorectal cancer in Quebec.Curr Oncol. 2015 Dec;22(6):e485-92. doi: 10.3747/co.22.2692. Curr Oncol. 2015. PMID: 26715887 Free PMC article.
-
Patterns of Pelvic Radiotherapy in Patients with Stage II/III Rectal Cancer.J Cancer Epidemiol. 2013;2013:408460. doi: 10.1155/2013/408460. Epub 2013 Oct 2. J Cancer Epidemiol. 2013. PMID: 24223589 Free PMC article.
-
Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.BMC Cancer. 2019 Jul 25;19(1):735. doi: 10.1186/s12885-019-5910-z. BMC Cancer. 2019. PMID: 31345187 Free PMC article.
-
A process mining approach for clinical guidelines compliance: real-world application in rectal cancer.Front Oncol. 2023 May 17;13:1090076. doi: 10.3389/fonc.2023.1090076. eCollection 2023. Front Oncol. 2023. PMID: 37265796 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources